Four leading medtech startups will take the stage at the 2026 Showcase & Grand Finals in Singapore, where a live audience vote will determine this year’s Grand Prize Winner.
LOS ANGELES & SINGAPORE – Oct. 16, 2026 – MedTech Innovator (MTI), the world’s largest and most impactful accelerator for medical technology startups, today announced the four finalists who will compete for the USD 175,000 Grand Prize at the 2026 MedTech Innovator Asia Pacific Showcase & Grand Finals on October 26, 2026, in Singapore.
The four finalists were selected from MedTech Innovator Asia Pacific’s 2026 cohort of 20 companies following a four-month accelerator program that brought together some of the most promising medical technology companies from across the region. An audience vote will determine the 2026 MedTech Innovator Asia Pacific Grand Prize Winner. Each of the three runners-up will receive USD 10,000.
The four companies competing for the 2026 MedTech Innovator Asia Pacific Grand Prize are:
- Ardens Lifescience (Busan, South Korea) – Transbronchial RF ablation system with a conforming electrode for peripheral lung cancer.
- BaiYi Healthcare (Shanghai, China) – World’s 1st AI-enabled, non-contact ocular signometer for standardized objective assessment and longitudinal monitoring of thyroid eye disease.
- Eyes of AI (Sydney, Australia) – Eyes of AI turns 2D and 3D dental imaging into clinical insights for disease detection and treatment planning, with commercial integrations reaching 130+ countries.
- Physiologas Technologies (Sagamihara, Japan) – A waterless hemodialysis system with dialysate recycling, ensuring accessibility, convenience, and sustainability.
“The diversity of this year’s Final Four reflects the breadth of innovation we continue to see across Asia Pacific, bringing together companies from different markets and with distinct approaches to addressing critical healthcare needs,” said Fredrik Nyberg, Managing Director of MedTech Innovator Asia Pacific. “Reaching the Final Four is a significant achievement. Each company has demonstrated a compelling solution, strong potential for clinical and commercial impact, and the ambition to scale beyond its home market. We look forward to seeing them take the stage in Singapore and giving our audience the opportunity to select the 2026 Grand Prize Winner.”
The Final Four were selected following an extensive evaluation process involving MedTech Innovator’s network of industry executives, investors, clinicians, and subject-matter experts. In 2026, MedTech Innovator Asia Pacific received more than 680 applications, with 67 companies selected to pitch before 20 companies advanced to the accelerator cohort.
Throughout the four-month program, the cohort participated in tailored mentorship, industry engagement, educational programming, and strategic discussions designed to advance their clinical, commercial, regulatory, fundraising, and market-access objectives. The program connects participating companies with MedTech Innovator’s global network while providing access to expertise and opportunities across the Asia Pacific healthcare ecosystem.
Ahead of the Grand Finals, all 20 cohort companies will take part in four themed Showcase Panels spanning AI, imaging and surgical innovation; breakthroughs in oncology; neuro, ophthalmology and renal care; and remote monitoring, respiratory care and gastrointestinal health. The event will also feature industry round table discussions focused on the latest trends shaping the medical technology innovation ecosystem in Asia Pacific.
The 2026 MedTech Innovator Asia Pacific Showcase & Grand Finals is open to industry leaders, investors, healthcare professionals, and the broader medtech community. Registration for the October 26 event is now open: https://luma.com/mevbjkod
MedTech Innovator Asia Pacific’s 2026 program partners include Johnson & Johnson MedTech, B. Braun Medical Industries, Siemens Healthineers, Blue Goat Cyber, Dovetail, Cambridge Consultants, The Mullings Group, and Enterprise Singapore joining as a 2026 partner to support regional expansion and innovation initiatives.
About MedTech Innovator
MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing more than 20,000 applicants and fostering the growth of 838 graduates. Alumni have collectively raised USD 12 billion in follow-on funding, seen 65 acquisitions, and introduced 500+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator Asia Pacific, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow MTI on LinkedIn, and subscribe to its monthly newsletter.
# # #
Media Contact:
Bernice Tan
Program & Marketing Manager
Leave a Reply